92 related articles for article (PubMed ID: 2697432)
1. Autologous bone marrow transplantation (ABMT) in poor prognosis diffuse non-Hodgkin's lymphomas (NHL). Report of Non-Hodgkin's Lymphoma Cooperative Study Group (NHLCSG).
Coser P; Santini G; Rizzoli V; Porcellini A; Chisesi T; Sertoli R; Contu A; Salvagno L; Vinante O; Rossi E
Bone Marrow Transplant; 1989 Dec; 4 Suppl 4():164. PubMed ID: 2697432
[No Abstract] [Full Text] [Related]
2. An EBMT registry matched study of allogeneic stem cell transplants for lymphoma: allogeneic transplantation is associated with a lower relapse rate but a higher procedure-related mortality rate than autologous transplantation.
Peniket AJ; Ruiz de Elvira MC; Taghipour G; Cordonnier C; Gluckman E; de Witte T; Santini G; Blaise D; Greinix H; Ferrant A; Cornelissen J; Schmitz N; Goldstone AH;
Bone Marrow Transplant; 2003 Apr; 31(8):667-78. PubMed ID: 12692607
[TBL] [Abstract][Full Text] [Related]
3. Prolonged disease-free survival after ablative chemoradiotherapy and autologous bone marrow transplantation in adult malignant lymphoma.
Da WM; Zhong JT; Liu Y; Huang YS; Bai H; Wu XX; Ou YX; Wang CB; Xu SF
Chin Med J (Engl); 1993 Apr; 106(4):277-81. PubMed ID: 8325155
[TBL] [Abstract][Full Text] [Related]
4. Role of autologous bone marrow transplantation in non-Hodgkin's lymphoma.
Vose JM; Armitage JO
Hematol Oncol Clin North Am; 1993 Jun; 7(3):577-90. PubMed ID: 8102135
[TBL] [Abstract][Full Text] [Related]
5. Prognostic factors for survival of non-Hodgkin's lymphoma patients treated with high-dose chemotherapy and autologous bone marrow transplantation.
de Kreuk M; Ossenkoppele GJ; Meijer CJ; Huijgens PC
Bone Marrow Transplant; 1996 Jun; 17(6):963-71. PubMed ID: 8807101
[TBL] [Abstract][Full Text] [Related]
6. Autologous bone marrow transplantation in patients with non-Hodgkin's lymphoma: comparison of different parameters in predicting the kinetics of haematological recovery.
Visani G; Dinota A; Verlicchi F; Bandini G; Ricci P; Motta MR; Rizzi S; Lemoli RM; Poluzzi C; Gherlinzoni F
Bone Marrow Transplant; 1988 Nov; 3(6):599-605. PubMed ID: 2905614
[TBL] [Abstract][Full Text] [Related]
7. Phase I/II study of high-dose cyclophosphamide, etoposide and cisplatin followed by autologous bone marrow or peripheral blood stem cell transplantation in patients with poor prognosis Hodgkin's disease or non-Hodgkin's lymphoma.
Klumpp TR; Mangan KF; Glenn LD; Malaspina DR; Cropper T; Mullaney M; Macdonald JS
Bone Marrow Transplant; 1993 Oct; 12(4):337-45. PubMed ID: 7506091
[TBL] [Abstract][Full Text] [Related]
8. Bone morphology after bone marrow transplantation for Hodgkin's and non-Hodgkin's lymphoma.
Michelson JD; Gornet M; Codd T; Torres J; Lanighan K; Jones R
Exp Hematol; 1993 Mar; 21(3):475-82. PubMed ID: 8440346
[TBL] [Abstract][Full Text] [Related]
9. Allogeneic bone marrow transplantation for Hodgkin's and non-Hodgkin's lymphoma.
Mendoza E; Territo M; Schiller G; Lill M; Kunkel L; Wolin M
Bone Marrow Transplant; 1995 Feb; 15(2):299-303. PubMed ID: 7773222
[TBL] [Abstract][Full Text] [Related]
10. Increasing incidence of late second malignancies after conditioning with cyclophosphamide and total-body irradiation and autologous bone marrow transplantation for non-Hodgkin's lymphoma.
Brown JR; Yeckes H; Friedberg JW; Neuberg D; Kim H; Nadler LM; Freedman AS
J Clin Oncol; 2005 Apr; 23(10):2208-14. PubMed ID: 15753460
[TBL] [Abstract][Full Text] [Related]
11. Results of a randomised, controlled, multicentre study of recombinant human granulocyte colony-stimulating factor (filgrastim) in patients with Hodgkin's disease and non-Hodgkin's lymphoma undergoing autologous bone marrow transplantation.
Schmitz N; Dreger P; Zander AR; Ehninger G; Wandt H; Fauser AA; Kolb HJ; Zumsprekel A; Martin A; Hecht T
Bone Marrow Transplant; 1995 Feb; 15(2):261-6. PubMed ID: 7539668
[TBL] [Abstract][Full Text] [Related]
12. Syngeneic hematopoietic stem-cell transplantation for non-Hodgkin's lymphoma: a comparison with allogeneic and autologous transplantation--The Lymphoma Working Committee of the International Bone Marrow Transplant Registry and the European Group for Blood and Marrow Transplantation.
Bierman PJ; Sweetenham JW; Loberiza FR; Taghipour G; Lazarus HM; Rizzo JD; Schmitz N; van Besien K; Vose JM; Horowitz M; Goldstone A;
J Clin Oncol; 2003 Oct; 21(20):3744-53. PubMed ID: 12963703
[TBL] [Abstract][Full Text] [Related]
13. Acute and chronic pulmonary complications following autologous bone marrow transplantation in non-Hodgkin's lymphoma.
Jochelson M; Tarbell NJ; Freedman AS; Rabinowe SN; Takvorian T; Soiffer R; Anderson K; Ritz J; Nadler LM
Bone Marrow Transplant; 1990 Nov; 6(5):329-31. PubMed ID: 2291994
[TBL] [Abstract][Full Text] [Related]
14. Autologous bone marrow transplantation for non-transformed low-grade non-Hodgkin's lymphoma.
Cervantes F; Shu XO; McGlave PB; Ramsay NK; Miller WJ; Kersey JH; Weisdorf DJ
Bone Marrow Transplant; 1995 Sep; 16(3):387-92. PubMed ID: 8535311
[TBL] [Abstract][Full Text] [Related]
15. Practice guidelines for the management of extranodal non-Hodgkin's lymphomas of adult non-immunodeficient patients. Part I: primary lung and mediastinal lymphomas. A project of the Italian Society of Hematology, the Italian Society of Experimental Hematology and the Italian Group for Bone Marrow Transplantation.
Zinzani PL; Martelli M; Poletti V; Vitolo U; Gobbi PG; Chisesi T; Barosi G; Ferreri AJ; Marchetti M; Pimpinelli N; Tura S; ; ;
Haematologica; 2008 Sep; 93(9):1364-71. PubMed ID: 18603558
[TBL] [Abstract][Full Text] [Related]
16. Impact of three courses of intensified CHOP prior to high-dose sequential therapy followed by autologous stem-cell transplantation as first-line treatment in poor-risk, aggressive non-hodgkin's lymphoma: comparative analysis of Dutch-Belgian Hemato-Oncology Cooperative Group Studies 27 and 40.
van Imhoff GW; van der Holt B; Mackenzie MA; Van't Veer MB; Wijermans PW; Ossenkoppele GJ; Schouten HC; Sonneveld P; Steijaert MM; Kluin PM; Kluin-Nelemans HC; Verdonck LF;
J Clin Oncol; 2005 Jun; 23(16):3793-801. PubMed ID: 15809447
[TBL] [Abstract][Full Text] [Related]
17. Successful autologous transplantation of immunomagnetic bead purged bone marrow in non-Hodgkin's lymphoma.
Ogniben E; Hohaus S; Kvalheim G; Dörken B; Haas R
Prog Clin Biol Res; 1992; 377():189-95. PubMed ID: 1438415
[No Abstract] [Full Text] [Related]
18. The treatment of relapsed or refractory intermediate grade non-Hodgkin's lymphoma with autologous bone marrow transplantation followed by cyclosporine and interferon.
Gryn J; Johnson E; Goldman N; Devereux L; Grana G; Hageboutros A; Fernandez E; Constantinou C; Harrer W; Viner E; Goldberg J
Bone Marrow Transplant; 1997 Feb; 19(3):221-6. PubMed ID: 9028549
[TBL] [Abstract][Full Text] [Related]
19. [Autologous stem-cell transplantations in children with non-Hodgkin lymphomas].
Wójcik B; Kowalczyk JR; Chybicka A; Wachowiak J; Drabko K; Zaucha-Prazmo A; Choma M; Gorczyńska E; Toporski J; Turkiewicz D; Kałwak K; Pieczonka A; Boruczkowski D
Przegl Lek; 2004; 61 Suppl 2():53-6. PubMed ID: 15686047
[TBL] [Abstract][Full Text] [Related]
20. Prognostic factors in patients who received autologous bone marrow transplantation for non-Hodgkin's lymphoma. Report of 104 patients from the Spanish Cooperative Group GEL/TAMO.
Conde E; Sierra J; Iriondo A; Domingo A; García Laraña J; Marín J; Caballero D; Martínez F; León A; García-Conde J
Bone Marrow Transplant; 1994 Aug; 14(2):279-86. PubMed ID: 7994243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
